VKTX logo

Viking Therapeutics (VKTX) Operating profit

annual operating profit:

-$150.92M-$50.09M(-49.68%)
December 31, 2024

Summary

  • As of today (May 29, 2025), VKTX annual operating income is -$150.92 million, with the most recent change of -$50.09 million (-49.68%) on December 31, 2024.
  • During the last 3 years, VKTX annual operating profit has fallen by -$95.24 million (-171.04%).
  • VKTX annual operating profit is now -149178.93% below its all-time high of -$101.10 thousand, reached on December 31, 2013.

Performance

VKTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXincome statement metrics

quarterly operating profit:

-$55.47M-$9.23M(-19.96%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VKTX quarterly operating income is -$55.47 million, with the most recent change of -$9.23 million (-19.96%) on March 31, 2025.
  • Over the past year, VKTX quarterly operating profit has dropped by -$21.40 million (-62.79%).
  • VKTX quarterly operating profit is now -1733306.25% below its all-time high of -$3200.00, reached on March 31, 2013.

Performance

VKTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXincome statement metrics

TTM operating profit:

-$172.32M-$21.40M(-14.18%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VKTX TTM operating income is -$172.32 million, with the most recent change of -$21.40 million (-14.18%) on March 31, 2025.
  • Over the past year, VKTX TTM operating profit has dropped by -$57.95 million (-50.68%).
  • VKTX TTM operating profit is now -157123.54% below its all-time high of -$109.60 thousand, reached on December 31, 2012.

Performance

VKTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVKTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

VKTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-49.7%-62.8%-50.7%
3 y3 years-171.0%-241.4%-198.7%
5 y5 years-361.7%-406.7%-367.9%

VKTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-171.0%at low-242.5%at low-198.7%at low
5 y5-year-361.7%at low-463.5%at low-367.9%at low
alltimeall time<-9999.0%at low<-9999.0%at low<-9999.0%at low

VKTX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$55.47M(+20.0%)
-$172.32M(+14.2%)
Dec 2024
-$150.92M(+49.7%)
-$46.24M(+26.5%)
-$150.92M(+12.7%)
Sep 2024
-
-$36.56M(+7.3%)
-$133.97M(+7.5%)
Jun 2024
-
-$34.05M(-0.1%)
-$124.68M(+9.0%)
Mar 2024
-
-$34.07M(+16.3%)
-$114.36M(+13.4%)
Dec 2023
-$100.83M(+43.3%)
-$29.29M(+7.4%)
-$100.83M(+9.8%)
Sep 2023
-
-$27.27M(+14.8%)
-$91.83M(+13.7%)
Jun 2023
-
-$23.74M(+15.6%)
-$80.76M(+8.2%)
Mar 2023
-
-$20.54M(+1.3%)
-$74.65M(+6.1%)
Dec 2022
-$70.36M(+26.4%)
-$20.28M(+25.2%)
-$70.36M(+12.4%)
Sep 2022
-
-$16.20M(-8.1%)
-$62.58M(+4.7%)
Jun 2022
-
-$17.63M(+8.5%)
-$59.79M(+3.6%)
Mar 2022
-
-$16.25M(+29.9%)
-$57.70M(+3.6%)
Dec 2021
-$55.68M(+30.5%)
-$12.51M(-6.7%)
-$55.68M(+2.3%)
Sep 2021
-
-$13.40M(-13.8%)
-$54.44M(+7.0%)
Jun 2021
-
-$15.54M(+9.2%)
-$50.88M(+10.7%)
Mar 2021
-
-$14.23M(+26.3%)
-$45.94M(+7.7%)
Dec 2020
-$42.66M(+30.5%)
-$11.27M(+14.5%)
-$42.66M(+5.9%)
Sep 2020
-
-$9.84M(-7.2%)
-$40.27M(+6.3%)
Jun 2020
-
-$10.61M(-3.1%)
-$37.87M(+2.8%)
Mar 2020
-
-$10.95M(+23.4%)
-$36.83M(+12.7%)
Dec 2019
-$32.69M
-$8.87M(+19.3%)
-$32.69M(+6.0%)
Sep 2019
-
-$7.44M(-22.3%)
-$30.85M(+0.1%)
Jun 2019
-
-$9.57M(+40.6%)
-$30.81M(+9.4%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$6.81M(-3.3%)
-$28.16M(+7.6%)
Dec 2018
-$26.16M(+37.2%)
-$7.04M(-4.8%)
-$26.16M(+11.1%)
Sep 2018
-
-$7.39M(+6.8%)
-$23.55M(+13.0%)
Jun 2018
-
-$6.92M(+44.1%)
-$20.85M(+10.3%)
Mar 2018
-
-$4.80M(+8.5%)
-$18.91M(-0.9%)
Dec 2017
-$19.07M(+37.7%)
-$4.43M(-5.6%)
-$19.07M(+3.8%)
Sep 2017
-
-$4.69M(-5.8%)
-$18.38M(+8.4%)
Jun 2017
-
-$4.98M(+0.3%)
-$16.95M(+9.0%)
Mar 2017
-
-$4.97M(+32.9%)
-$15.55M(+12.3%)
Dec 2016
-$13.85M(+15.4%)
-$3.74M(+14.5%)
-$13.85M(-6.0%)
Sep 2016
-
-$3.26M(-8.8%)
-$14.73M(-6.5%)
Jun 2016
-
-$3.58M(+9.5%)
-$15.75M(+6.4%)
Mar 2016
-
-$3.27M(-29.3%)
-$14.80M(+23.4%)
Dec 2015
-$12.00M(-48.9%)
-$4.62M(+7.7%)
-$12.00M(+55.2%)
Sep 2015
-
-$4.29M(+63.2%)
-$7.73M(+68.4%)
Jun 2015
-
-$2.63M(+469.8%)
-$4.59M(-80.6%)
Mar 2015
-
-$461.00K(+30.4%)
-$23.72M(+1.1%)
Dec 2014
-$23.47M(>+9900.0%)
-$353.60K(-69.2%)
-$23.47M(+1.5%)
Sep 2014
-
-$1.15M(-94.7%)
-$23.11M(+5.2%)
Jun 2014
-
-$21.76M(>+9900.0%)
-$21.97M(+9589.1%)
Mar 2014
-
-$209.70K(+1133.5%)
-$226.70K(+74.7%)
Dec 2013
-$101.10K
-
-
Jun 2013
-
-$17.00K(+431.3%)
-$129.80K(+15.1%)
Mar 2013
-
-$3200.00(-97.1%)
-$112.80K(+2.9%)
Dec 2012
-
-$109.60K
-$109.60K

FAQ

  • What is Viking Therapeutics annual operating income?
  • What is the all time high annual operating profit for Viking Therapeutics?
  • What is Viking Therapeutics annual operating profit year-on-year change?
  • What is Viking Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Viking Therapeutics?
  • What is Viking Therapeutics quarterly operating profit year-on-year change?
  • What is Viking Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Viking Therapeutics?
  • What is Viking Therapeutics TTM operating profit year-on-year change?

What is Viking Therapeutics annual operating income?

The current annual operating profit of VKTX is -$150.92M

What is the all time high annual operating profit for Viking Therapeutics?

Viking Therapeutics all-time high annual operating income is -$101.10K

What is Viking Therapeutics annual operating profit year-on-year change?

Over the past year, VKTX annual operating income has changed by -$50.09M (-49.68%)

What is Viking Therapeutics quarterly operating income?

The current quarterly operating profit of VKTX is -$55.47M

What is the all time high quarterly operating profit for Viking Therapeutics?

Viking Therapeutics all-time high quarterly operating income is -$3200.00

What is Viking Therapeutics quarterly operating profit year-on-year change?

Over the past year, VKTX quarterly operating income has changed by -$21.40M (-62.79%)

What is Viking Therapeutics TTM operating income?

The current TTM operating profit of VKTX is -$172.32M

What is the all time high TTM operating profit for Viking Therapeutics?

Viking Therapeutics all-time high TTM operating income is -$109.60K

What is Viking Therapeutics TTM operating profit year-on-year change?

Over the past year, VKTX TTM operating income has changed by -$57.95M (-50.68%)
On this page